Intimation of Re-appointment of Directors.

Date: 12-08-2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G Listing Department Bandra Kurla Complex, Dalal Street, Bandra East, Mumbai-400051 Mumbai-400001 Scrip Code: MUKKA Scrip Code: 544135 Dear Sir/Madam, Subject: Changes in Directorate – Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) Pursuant to Regulation 30(6) read with Schedule III and other applicable provisions of the SEBI Listing Regulations, we hereby inform you that basis recommendations of the Nomination and Remuneration Committee and subject to approval of the members of the Company at the ensuing 16th Annual General Meeting of the Company, the Board of Directors of the Company at their meeting held today, i.e. Wednesday, 12th August 2026, inter alia, approved the following: 1. Re-appointment of Mr. Karkala Shankar Balachandra Rao (DIN: 03589394) as a Non- Executive Independent Director of the Company not being liable to retire by rotation, for a 2nd term of five consecutive years commencing from 15th January 2027 to 14th January 2032 (both days inclusive) subject to approval of the shareholders of the Company at the ensuing 16th Annual General Meeting of the Company as outlined in Annexure-I. 2. Re-appointment of Mr. Hamad Bava (DIN: 09448423) as a Non-Executive Independent Director of the Company not being liable to retire by rotation, for a 2nd term of five consecutive years commencing from 15th January 2027 to 14th January 2032 (both days inclusive) subject to approval of the shareholders of the Company at the ensuing 16th Annual General Meeting of the Company as outlined in Annexure-I. 3. Re-appointment of Mr. Narendra Surendra Kamath (DIN: 07255904) as a Non-Executive Independent Director of the Company not being liable to retire by rotation, for a 2nd term of five consecutive years commencing from 15th January 2027 to 14th January 2032 (both days inclusive) subject to approval of the shareholders of the Company at the ensuing 16th Annual General Meeting of the Company as outlined as outlined in Annexure-I. 4. Re-appointment of Mr. Kalandan Mohammed Haris (DIN: 03020471) as Managing Director and Chief Executive Officer of the Company, to hold office for a further period of 5 (Five) years with effect from 20th January 2027 to 19th January 2032 (both days inclusive) whose office as a Managing Director shall not be liable to retire by rotation in an annual general meeting subject to approval of the shareholders of the Company at the ensuing 16th Annual General Meeting of the Company as outlined as outlined in Annexure-II 5. Re-appointment of Mr. Kalandan Mohammed Althaf (DIN:03051103) as Whole-Time Director and Chief Financial Officer of the Company, to hold office for a further period of 5 (Five) years with effect from 20th January 2027 to 19th January 2032 (both days inclusive) whose office as a Director shall be liable to retire by subject to approval of the shareholders of the Company at the ensuing 16th Annual General Meeting of the Company as outlined as outlined in Annexure- 6. Re-appointment of Mr. Kalandan Mohammad Arif (DIN:03020564) as Whole-Time Director and Chief Operating Officer of the Company, to hold office for a further period of 5 (Five) years with effect from 20th January 2027 to 19th January 2032 (both days inclusive) whose office as a Director shall be liable to retire by rotation subject to approval of the shareholders of the Company at the ensuing 16th Annual General Meeting of the Company as outlined as outlined in Annexure-II. The detailed disclosure as required under SEBI Circular No. SEBI/HO/CFD/CFDPoD1/P/CIR/2023/123 dated July 13, 2023 and such other circulars as applicable, including amendments thereon, are provided in Annexure I and II to this letter The Meeting commenced at 03:30 p.m. and concluded at 4:15 p.m. This is for your information and records. Thank you, For Mukka Proteins Limited Mehaboobsab Mahmadgous Chalyal Company Secretary & Compliance Officer Membership No.: A67502 Encl: as above. Annexure – I S. Particulars Details No. Mr. Karkala Shankar Mr. Hamad Bava Mr. Narendra Surendra Balachandra Rao Kamath 1. Reason for Change viz. The Board of Directors have The Board of Directors have The Board of Directors appointment, re- at their meeting held today at their meeting held today have at their meeting held appointment, viz. Wednesday, 12th viz. Wednesday, 12th August today viz. Wednesday, resignation, removal, August 2026, on the basis of 2026, on the basis of 12th August 2026, on the death or otherwise recommendation of the recommendation of the basis of recommendation Nomination and Nomination and of the Nomination and Remuneration Committee, Remuneration Committee, Remuneration Committee, approved the re-appointment approved the re-appointment approved the re- of Mr. Karkala Shankar of Mr. Hamad Bava (DIN: appointment of Mr. Balachandra Rao (DIN: 09448423) as the Narendra Surendra 03589394) as the Independent Director of the Kamath (DIN: 07255904) Independent Director of the Company, not being liable to as the Independent Company, not being liable to retire by rotation, for a 2nd Director of the Company, retire by rotation, for a 2nd term of five consecutive not being liable to retire by term of five consecutive years commencing from 15th rotation, for a 2nd term of years commencing from 15th January 2027 to 14th January five consecutive years January 2027 to 14th January 2032 (both days inclusive), commencing from 15th 2032 (both days inclusive), subject to approval of the January 2027 to 14th subject to approval of the shareholders of the Company January 2032 (both days shareholders of the Company at the ensuing 16th Annual inclusive), subject to at the ensuing 16th Annual General Meeting of the approval of the General Meeting of the Company. shareholders of the Company. Company at the ensuing 16th Annual General Meeting of the Company. 2. Date of appointment / Date of re-appointment – Date of re-appointment – Date of re-appointment – re-appointment w.e.f.15th January 2027 w.e.f. 15th January 2027 w.e.f. 15th January 2027 /cessation (as Term of Re-appointment – Term of Re-appointment – Term of Re-appointment – applicable) & term of 2nd term of five consecutive 2nd term of five consecutive 2nd term of five appointment / re- years commencing from 15th years commencing from 15th consecutive years appointment January 2027 to 14th January January 2027 to 14th January commencing from 15th 2032 (both days inclusive) 2032 (both days inclusive) January 2027 to 14th January 2032 (both days inclusive) 3. Brief Profile He has worked for Canara He was previously employed He previously worked Bank in various capacities with Vijaya Bank from the with Reliance Big from 1973 to 2014. He was year 1975 to 2012. He has Entertainment Private previously a Director of over 35 (thirty-five) years of Limited as Vice President- Canara Bank Securities experience in banking sector. Finance from May 28, Limited from September 16, He has also served as Finance 2019 to February 12, 2011 to March 31, 2014. He Manager at Yenepoya 2021. He has also served has over 40 years of Institute of Medical Sciences as a Director in Reliance experience in Banking, and Research Private Big Entertainment Private Credit, Foreign Exchange Limited, Mangaluru for a Limited, Reliance etc. period of 7 years from year Entertainment Ventures 2013 to 2019. He is a Private Limited, Zapak member of a Non- Mobile Games Private Governmental Organisation - Limited and Big Flicks Jamiyyatul Falah, Mangaluru Private Limited. Corporation Unit. 4. Disclosure of Not Applicable Not Applicable Not Applicable relationship between Directors 5. Information as Mr. Karkala Balachandra Mr. Hamad Bava is not Mr. Narendra Surendra required pursuant to Rao is not debarred from debarred from holding the Kamath is not debarred BSE Circular [Showing first 8,000 characters — download PDF for full document]